Factors affecting death in COVID-19 patients with neurological disease manifestations

Authors

  • Andika Okparasta Department of Neurology, Central General Hospital Dr. Mohammad Hoesin, Faculty of Medicine Universitas Sriwijaya, Palembang, Indonesia
  • Eka Azwinda Department of Neurology, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia

DOI:

https://doi.org/10.18203/2320-6012.ijrms20222512

Keywords:

COVID-19, Neurological manifestations, Risk factors for death, SARS-COV-2

Abstract

Background: Coronavirus disease-2019 (COVID-19) can also attack the nervous system besides the respiratory system. It is recorded that 25% of all COVID-19 cases are accompanied by neurological disorders with a higher death rate. The study aimed to determine the neurological manifestations of COVID-19 and analyse the factors that contribute to death in COVID-19 with neurological disorders.

Methods: This was an analytical cross-sectional study that included 183 patients with COVID-19 and neurological disorders at the Department of Neurology Dr. Mohammad Hoesin Central General Hospital, Palembang, Indonesia from March 2020 to June 2021. We evaluated the risk factor for mortality in COVID-19 patients with neurological disorders.

Results: In this study, 78.1% of patients were under 65 years old, and 89% were male with hypertension (51.4%) as the most comorbid disease. A total of 66.1% of the study subjects had peripheral leukocytes 10,000/mm3, with 82% having an NLR value of 3.3. The mortality rate of COVID-19 patients with neurological disorders is 30.1%. Neurological manifestations recorded were CVD (71.3%), encephalitis meningitis, seizures, exacerbation of myasthenia gravis, GBS, and myelitis. The bivariate analysis found no risk factors associated with death in COVID-19 patients with neurological disorders. Multivariate regression analysis obtained that male sex and diabetes mellitus have a correlation with death in COVID-19 accompanied by neurological disorders.

Conclusions: Male COVID-19 patients with neurological manifestations and diabetes mellitus have a higher risk for death.

Author Biography

Andika Okparasta, Department of Neurology, Central General Hospital Dr. Mohammad Hoesin, Faculty of Medicine Universitas Sriwijaya, Palembang, Indonesia

Neurology

References

Alsuliman T, Sulaiman R, Ismail S, Srour M, Alrstom A. COVID-19 paraclinical diagnostic tools: Updates and future trends. Curr Res Transl Med. 2020;68(January):83-91.

Perkembangan ST. COVID-19, 2021. Available at: https://infeksiemerging.kemkes.go.id/document/situasi-terkinperkembangancovid1915mare. Accessed on 20 July 2022.

Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, et al. Neurological Manifestations of COVID-19 (SARS-CoV-2): a review. Front Neurol. 2020;11:1-9.

Hogan RE, Grinspan Z, Axeen E, Marquis B, Day BK. COVID-19 in patients with seizures and epilepsy: interpretation of relevant knowledge of presenting signs and symptoms. Epilepsy Curr. 2020;20(5):312-5.

Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020;80(4):401-6.

Asadi-Pooya AA. Seizures associated with coronavirus infections. Seizure Eur J Epilepsy. 2020;79:49-52.

Pratigno H, Thiomas P, Setiastuti H, Usyanara, Rahaya F, Nuriah V. Neurological Manifestations in COVID-19 Patients at the Tangerang City Regional General Hospital as a COVID-19 Referral Center in Banten Province, Indonesia. 2020.

Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allerg Clin Immunol. 2020;146(1):110-8.

Hu J, Wang Y. The clinical characteristics and risk factors of severe COVID-19. Gerontology. 2021;67(3):255-66.

Orsucci D, Ienco EC, Nocita G, Napolitano A, Vista M. Neurological features of COVID-19 and their treatment: a review. Drugs Context. 2020;9:1-12.

Yang A, Liu J, Tao W, Li H. The diagnostic and predictive role of NLR, d-NLR, and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504.

Giannouchos TV, Sussman RA, Odriozola JM, Poulas K, Farsalinos K. Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases. Medrxiv. 2020.

Downloads

Published

2022-09-27

How to Cite

Okparasta, A., & Azwinda, E. (2022). Factors affecting death in COVID-19 patients with neurological disease manifestations. International Journal of Research in Medical Sciences, 10(10), 2100–2106. https://doi.org/10.18203/2320-6012.ijrms20222512

Issue

Section

Original Research Articles